In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]
Silk Road Medical
Boston Scientific closes Silk Road Medical acquisition
Boston Scientific announced today that it completed its $1.18 billion acquisition of Silk Road Medical . The acquisition includes a purchase price of $27.50 per share for a full enterprise value of approximately $1.18 billion. Boston Scientific expects an immaterial impact from the acquisition on its adjusted EPS in 2024 and 2025. It expects an accretive […]
Boston Scientific expected to close Silk Road Medical acquisition soon after antitrust waiting period expires
Silk Road Medical today filed with the SEC to confirm the expiration of an antitrust waiting period for its merger with Boston Scientific . In June, Boston Scientific announced that it agreed to acquire Silk Road Medical in a deal worth approximately $1.16 billion. Sunnyvale, California-based Silk Road Medical develops products designed to prevent stroke […]
Procyrion adds Silk Road Medical exec to its board
Procyrion — developer of the catheter-deployed Aortix percutaneous mechanical circulatory support device — has a new board member. Lucas Buchanan is the COO of Sunnyvale, California–based Silk Road Medical. Boston Scientific is in the process of acquiring Silk Road and its technology to prevent stroke in patients with carotid artery disease in a $1.16 billion […]
Boston Scientific, Silk Road Medical delay merger to give FTC more time
Boston Scientific recently withdrew its premerger notification and report form to give the U.S. Federal Trade Commission more time to review the proposed acquisition of Silk Road Medical . The Marlborough, Massachusetts–based company voluntarily withdrew and plans to refile its premerger notification report (HSR) form with the FTC, according to an SEC filing. Silk Road […]
Boston Scientific to acquire Silk Road Medical for $1.16B
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire Silk Road Medical (Nasdaq:SILK) in a deal worth approximately $1.16 billion. Marlborough, Massachusetts–based Boston Scientific agreed to purchase Silk Road Medical at a price of $27.50 per share. Sunnyvale, California-based Silk Road Medical develops products designed to prevent stroke in patients with carotid artery disease. […]
Silk Road Medical launches new transcarotid stent in the U.S.
Silk Road Medical (Nasdaq:SILK) announced today that it launched its tapered EnRoute transcarotid stent system in the U.S. Sunnyvale, California-based Silk Road says this expands upon the prior launch of its EnRoute system by adding additional configurations. It better tailors the transcarotid artery revascularization (TCAR) procedure to the patient anatomy. TCAR, a minimally invasive procedure, […]
Silk Road Medical names a new CEO
Silk Road Medical (Nasdaq:SILK) announced today that it appointed Chas McKhann as its new CEO, effective immediately. Located in Sunnyvale, California and Plymouth, Minnesota, Silk Road Medical is focused on reducing stroke risk through a carotid artery disease treatment called TransCarotid Artery Revascularization (TCAR). The company announced last month that CEO Erica Rogers intended to […]
Silk Road Medical CEO announces retirement
Silk Road Medical (Nasdaq:SILK) today announced that CEO Erica Rogers plans to retire from the company. Rogers will formally retire once the succession process is completed. The Sunnyvale, California-based company is working with executive search firm Spencer Stuart to find a replacement CEO. “I’d like to thank Erica for her tremendous contributions to Silk Road […]
Silk Road Medical ticks up on Street-beating Q3 results
Silk Road Medical (NSDQ:SILK) this week posted third-quarter results that beat the overall consensus on Wall Street. The Sunnyvale, California-based stroke treatment tech company reported net losses of $10.3 million, or -29¢ per share, on sales of $37.4 million for the three months ended Sept. 30, on sales growth of 51.31% and profit gain from […]
Silk Road Medical announces $100M offering
Silk Road Medical (NSDQ:SILK) announced that it commenced a proposed underwritten public offering of $100 million in common stock. The Sunnyvale, California–based stroke treatment tech company plans to use proceeds to expand its sales force and operations. It also intends to increase its R&D activities, conduct or sponsor clinical trials and lease new facilities. Silk […]
